The Limited Company Research And Development Company "Medbiopharm"
发明人:
申请号：
EP18866610.1
公开号：
EP3695842A1
申请日:
2018.10.11
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The invention relates to the field of healthcare, namely, to the treatment of socially significant diseases, such as complications of diabetes mellitus, atherosclerosis, rheumatoid arthritis, osteoarthritis, neurodegenerative diseases including Alzheimer's and Parkinson's diseases, cataract, age-related diseases, etc.The essence of the invention is the use of sulfasalazine (international non-proprietary name； synonyms: Salazosulfapyridine, Azopyrine, Asulfidine, Salazopyridin, Salazopyrin, Salazosulfapyridine, Salicylazosulfapyridin, Salisulf, Sulfasalazyn, Sulphasalazine) of the general formula I as an inhibitor of the formation of advanced glycation end-products:
